Correlation Between Takeda Pharmaceutical and Dynavax Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Dynavax Technologies, you can compare the effects of market volatilities on Takeda Pharmaceutical and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Dynavax Technologies.

Diversification Opportunities for Takeda Pharmaceutical and Dynavax Technologies

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Takeda and Dynavax is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Dynavax Technologies go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Dynavax Technologies

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Dynavax Technologies. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 3.15 times less risky than Dynavax Technologies. The stock trades about -0.1 of its potential returns per unit of risk. The Dynavax Technologies is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  1,185  in Dynavax Technologies on September 1, 2024 and sell it today you would earn a total of  106.00  from holding Dynavax Technologies or generate 8.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Takeda Pharmaceutical Co  vs.  Dynavax Technologies

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Dynavax Technologies 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Dynavax Technologies are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Dynavax Technologies showed solid returns over the last few months and may actually be approaching a breakup point.

Takeda Pharmaceutical and Dynavax Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and Dynavax Technologies

The main advantage of trading using opposite Takeda Pharmaceutical and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.
The idea behind Takeda Pharmaceutical Co and Dynavax Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation